Asociación Puertorriqueños en Marcha (PA)

1900 N 9th St Philadelphia, PA 19122

Asociación Puertorriqueños en Marcha, in Philadelphia, is dedicated to providing a broad range of services, from detoxification to mental health treatment, and care for co-occurring disorders. They are committed to helping adults, children/adolescents, and seniors navigate their recovery journey by providing a detoxification program, mental health therapy, and comprehensive care for those with co-occurring disorders. They offer a variety of payment methods including medicare, medicaid, cash or self-payment, and state welfare or child and family services funds for their services. The staff at Asociación Puertorriqueños en Marcha is dedicated to providing expert care in a supportive environment.

Call Now

About Asociación Puertorriqueños en Marcha Pennsylvania PA

What To Expect From This Facility

View more rehab centers in Pennsylvania

A drug treatment facility provides an array of crucial services, including inpatient and outpatient treatment, substance use treatment, detoxification, and mental health support. The inpatient and outpatient programs offer structured therapy sessions and recovery guidance, catering to varying patient needs. Substance use treatment addresses specific drug dependencies, facilitating a safer path towards sobriety. Detoxification services aid in the physical cleansing of harmful substances, while mental health support ensures holistic recovery, helping individuals cope with psychological challenges accompanying addiction.

Type of Care: Substance use treatment; Mental health treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults / serious emotional disturbance in children

Facility Operation (e.g., Private, Public): Private non-profit organization

Payment/Insurance/Funding Accepted: Medicare; Medicaid; Cash or self-payment; State welfare or child and family services funds

Payment Assistance Available: Payment assistance (check with facility for details); Sliding fee scale (fee is based on income and other factors)

Special Programs/Groups Offered: Young adults; Seniors or older adults; Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ); Veterans; Criminal justice (other than DUI/DWI)/Forensic clients; Clients with co-occurring mental and substance use disorders; Clients with HIV or AIDS; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced trauma; Persons experiencing first-episode psychosis; Persons with post-traumatic stress disorder (PTSD); Children/adolescents with serious emotional disturbance (SED); Persons 18 and older with serious mental illness (SMI)

Assessment/Pre-treatment: Screening for tobacco use

Testing: Metabolic syndrome monitoring

Recovery Support Services: Housing services; Mentoring/peer support

Service Setting (Outpatient, Inpatient, etc.): Outpatient

Education and Counseling Services: Smoking/vaping/tobacco cessation counseling

Facility Smoking Policy: Smoking not permitted

Age Groups Accepted: Adults; Children/adolescents; Seniors

Language Services: Spanish

Facility Type: Outpatient mental health facility

Facility Vaping Policy: Vaping not permitted

Ancillary Services: Court-ordered outpatient treatment; Family psychoeducation; Supported housing; Case management service; Suicide prevention services

Pharmacotherapies: Lurasidone; Olanzapine; Quetiapine; Risperidone; Ziprasidone; Antipsychotics used in treatment of SMI

Treatment Approaches: Activity therapy; Cognitive behavioral therapy; Couples/family therapy; Group therapy; Integrated Mental and Substance Use Disorder treatment; Individual psychotherapy

Emergency Mental Health Services: Crisis intervention team

Get Confidential Help Now

Call us to see if this facility is right for you

Asociación Puertorriqueños en Marcha Services

Details About Services Offered By Facility

View rehab centers that offer similar services

Lurasidone

Lurasidone is another medication that belongs to the class of drugs known as atypical antipsychotics. It is approved by the United States Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar depression. It works by modulating the activity of certain neurotransmitters in the brain, including dopamine and serotonin. By doing so, it can help to reduce the symptoms of schizophrenia, such as hallucinations, delusions, and disorganized thinking, as well as the symptoms of bipolar depression.

Olanzapine

Olanzapine, an atypical antipsychotic, is primarily prescribed for the treatment of bipolar disorder and schizophrenia. It can be used for both long-term maintenance and new-onset disease in schizophrenia, and can be administered orally or via intramuscular injection.

Quetiapine

An atypical antipsychotics used to treat schizophrenia, bipolar disorder, and major depressive disorder by reducing the symptoms of schizophrenia, bipolar disorder, and major depressive disorder, such as hallucinations, delusions, mood swings, and sleep disturbances. Aunique aspect of Quetiapine is that it has been associated with a relatively lower risk of extrapyramidal symptoms (EPS) compared to some other antipsychotics. EPS are a set of movement disorders that can occur with the use of antipsychotic medications, and can include symptoms such as tremors, muscle stiffness, and involuntary movements. While Quetiapine may still cause EPS in some individuals, it is generally considered to have a lower risk of these symptoms compared to other antipsychotics.

Risperidone

Risperidone also an atypical antipsychotics thats used in the treatment of schizophrenia, bipolar disorder, and irritability associated with autism, may differ from similar medications in its class because its able to be administered via a long-acting injection that is given every two weeks. This can be particularly helpful for individuals who have difficulty adhering to a medication regimen, as it ensures that the medication is consistently delivered to the body.

Ziprasidone

Ziprasidone is a medication that belongs to the class of drugs known as atypical antipsychotics. It is approved by the United States Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder. One unique feature of Ziprasidone is that it may have a lower risk of causing weight gain compared to some other atypical antipsychotics. This can be particularly beneficial for individuals who are already at risk for metabolic disorders, such as diabetes or heart disease, as weight gain can exacerbate these conditions. Additionally, Ziprasidone may have a lower risk of causing sedation or cognitive impairment compared to some other antipsychotics.

Antipsychotics used in treatment of SMI

A multi-disciplinary clinical team approach helps individuals with serious mental illness to live in the community by offering 24-hour intensive services within their natural surroundings.

*The source of the presented data is SAMHSA, (Substance Abuse and Mental Health Services Administration).

Have a question?

REVIEWS

Asociación Puertorriqueños en Marcha Treatment Center Reviews From The Web

Read what people have to say

jose pereira

Year 2020

Asociación Puertorriqueños en Marcha (PA)

What To Expect From This Facility

Details About Services Offered By Facility

Asociación Puertorriqueños en Marcha Treatment Center Reviews From The Web

Facilities that specialize in addiction treatment

Read About The Latest News From Asociación Puertorriqueños en Marcha

Begin Healing Now !